Guidelines
Key Populations
UNAIDS/10.03E / JC1767E (English original, March 2010) ISBN 978 92 9 173849 6
USAID Office of HIV/AIDS
March 8-9, 2016
EClinicalMedicine 1 (2018) 21–27
https://doi.org/10.1016/j.eclinm.2018.06.005
2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
EClinicalMedicine: journal homepage: https://www.jo...urnals.elsevier.com/ eclinicalmedicine
Research Paper
more
HIV drug resistance , Users Manual
December 2017
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
HIV patient monitoring and case surveillance
Strengthening Community responses to HIv Treatment and Prevention
A toolkit to equip young people with the skills to become powerful advocates for Youth Sexual Reproductive Health and Rights (YSRH&R)
Accessed: 17.11.2019
Vision 2030
Accessed: 17.11.2019
Policy Brief
November 2014
It's time to deliver differently.
Accessed: 13.11.2019
L’accessibilité géographique et financière constante des médicaments essentiels de qualité,
sûrs et efficaces aux populations est un objectif majeur des politiques pharmaceutiques
nationales.
Pour atteindre cet objectif, le Ministère de la Santé du Burkina Faso a mis en place un systèm...e
public d’approvisionnement en médicaments essentiels qui repose sur la Centrale d'Achat des
médicaments essentiels et consommables médicaux (CAMEG) et ses agences commerciales
régionales et sur les dépôts répartiteurs de districts (DRD) avec un système de recouvrement
des coûts des produits pharmaceutiques.
more
Regional Initiative for the Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in Latin America and the Caribbean